Author

Véronique Crutel

Observed names: V. Crutel, V. Strijckmans Crutel, Véronique Strijckmans Crutel

Institution: Institut de Recherches Internationales Servier (France)

Observed institution: Institut de Recherches Internationales Servier (France)

ORCID: 0000-0003-0261-0999

Observed ORCID: 0000-0003-0261-0999

OpenAlex ID: A5032044129

Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies

2023 · Joaquin Fuentes, Mara Parellada, et al. · Autism Research · 47

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

2020 · Véronique Crutel, Estelle Lambert, et al. · Journal of Autism and Developmental Disorders · 32

Comparable efficacy and safety of 8 weeks treatment with agomelatine 25–50 mg or fluoxetine 20–40 mg in Asian out-patients with major depressive disorder

2013 · L. Shu, A.H. Sulaiman, et al. · Asian Journal of Psychiatry · 20

A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics

2022 · Christina Georgoula, Maite Ferrin, et al. · Child Psychiatry & Human Development · 15

Efficacy of Tianeptine 25–50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study

2018 · Robin Emsley, Antti Ahokas, et al. · The Journal of Clinical Psychiatry · 15

Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

2021 · Véronique Crutel, Estelle Lambert, et al. · Journal of Autism and Developmental Disorders · 11

P.809 Correlation between childhood autism rating scale 2 and clinical global impression improvement

2019 · B. Falissard, C. Albarran Severo, et al. · European Neuropsychopharmacology · 2

P.0349 Sensitivity to detect a change in patients with clinical global improvement using the childhood autism rating scale (CARS)

2021 · V. Crutel, E. Lambert, et al. · European Neuropsychopharmacology

Works count: 8

Citation count: 142

H-index: 6

I10-index: 6